4th Annual Cell Therapy Analytical Development 2022 The Westin Boston Seaport District, Boston

Returning for the 4th year, the Cell Therapy Analytical Development Summit is the leading industry-defining forum made exclusively for analytical, process development, CMC, QC, and regulatory experts.

New for 2022, take advantage of two tracks of content showcasing;

Pre-IND and Early Clinical Development
– Exploring Assay Development for Best-in-Class Early-Stage Characterization
– Establishing the Safety of Cell Therapy Products with Comprehensive Analytics
– Starting with the End-in-Mind: Considerations for Raw and Starting Material Analysis
– Optimizing Early-Stage Analytics to Bolster Speed to IND Submission and Phase 1 Launch

Clinical Development and Commercialization
– Improving Method Validation to Prepare for Successful Clinical Production
– Approaching Later-Stage Analytical and Process Technology Transfers
– Scaling Up from Clinical Development to Commercialization and Preparing for Release
– Optimizing Analytics During Manufacturing, Dealing with Process Changes

And don’t miss out on all of our plenary presentations!

… as well as a variety of plenary presentations and pre-conference workshops to equip your team with the lessons learned to achieve success in analytical submission from pre-IND through to commercialization.

Learn from analytical trailblazers at BMS, Kite, Novartis, Takeda, and more to support your efforts in developing safe and effective cell therapies.